Table 1.
Participant demographic data
| Characteristic | Number (SD, range) Total n = 11 |
Percent |
|---|---|---|
| Gender | ||
| Male | 7 | 63.6 |
| Female | 4 | 36.4 |
| Other | 0 | 0 |
| Age at consent (years) | ||
| All participants | 61.8 (20.9, 19.8–81.5) | |
| Male | 67.1 (18.9, 32.2–81.5) | |
| Female | 52.6 (23.8, 19.8–76.6) | |
| Preference for survey delivery | ||
| SMS | 5 | 45.5 |
| 6 | 54.4 | |
| Time on study | ||
| Full study period completed | 8 | 72.7 |
| Full study period not completed | 3 | 27.3 |
| Reason for not completing study period | ||
| Death | 1 | 9.1 |
| Discontinued clinical trial | 1 | 9.1 |
| Participant decision | 1 | 9.1 |
| Cancer type | ||
| Hodgkin lymphoma | 1 | 9.1 |
| Amyloidosis | 4 | 36.4 |
| Non-small cell lung cancer | 1 | 9.1 |
| Squamous cell carcinoma | 2 | 18.2 |
| Multiple myeloma | 1 | 9.1 |
| Desmoid tumour | 1 | 9.1 |
| Intrahepatic cholangiocarcinoma | 1 | 9.1 |